arrow
A

Anwar R. Padhani

Mount Vernon Cancer Centre
H指数:99
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Balancing harm minimization and oncological safety in MRI-informed prostate cancer screening

在MRI引导的前列腺癌筛查中平衡伤害最小化与肿瘤学安全性

2026-11-110
OA
PROSTATE IMAGING STANDARDS FOR SCREENING MAGNETIC RESONANCE IMAGING (PRISM): INTERNATIONAL CONSENSUS RECOMMENDATIONS

前列腺影像标准用于筛查磁共振成像(PRISM):国际共识建议

2026-05-010
PRE
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancer

ESUR:PSMA-PET/CT和全身MRI在晚期前列腺癌中的机遇

2025-11-050
OAAI
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study

人工智能驱动的前列腺癌检测:一项多中心、多扫描仪验证研究

2025-02-285
OA
Value of Whole-body Magnetic Resonance Imaging Using the MET-RADS-P Criteria for Assessing the Response to Intensified Androgen Deprivation Therapy in Metastatic Hormone-naïve and Castration-resistant Prostate Cancer

全身磁共振成像使用MET-RADS-P标准评估转移性激素敏感性和去势抵抗性前列腺癌对强化雄激素剥夺治疗的反应价值

2024-11-010
OAAI
PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer
2024-09-018
OA
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations
2024-05-017
OA
The Lancet Commission on prostate cancer: planning for the surge in cases

柳叶刀前列腺癌委员会: 规划病例激增

LANCET
IF88.5
2024-04-0157
OAAI
The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature

正电子发射断层扫描成像和肿瘤分子分析对原发性或复发性前列腺癌患者的风险分层,治疗选择和肿瘤学结果的影响: 现有文献的国际合作综述

2024-02-018
PRE
Prostagram magnetic resonance imaging in a screening population: Prostate Imaging-Reporting and Data System or Likert?

筛查人群中的前列腺素磁共振成像: 前列腺成像-报告和数据系统或Likert?

2023-10-160
OAAI